Durata Therapeutics, Inc. Names Allison Wey as Vice President, Investor Relations and Public Affairs

Durata Therapeutics, Inc. Names Allison Wey as Vice President, Investor Relations and Public Affairs

10/15/2012 9:48:53 AM

MORRISTOWN, N.J.--Durata Therapeutics (NASDAQ: DRTX) today announced the appointment of Allison Wey as the company's vice president of Investor Relations and Public Affairs. Ms. Wey, who joined the company's Chicago office today, brings to Durata more than 25 years of experience in investor relations, financial communications and corporate communications. "We welcome Allison to our senior management team as we enter a critical period of the company's development," said Durata Chief Executive Officer Paul R. Edick. "Three months into our progression as a public company, and as we approach significant clinical, regulatory and commercialization milestones that will be important drivers of the company's value, Allison will contribute greatly to Durata's growth and success."

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Polyphor is developing an inhaled version of murepavadin, which targets Pseudomonas aeruginosa infections, but is currently given intravenously.

Japanese pharma Astellas is looking to offload a series of unwanted research projects ahead of Thanksgiving; if you want one, it’s made it very easy.

A re-engineered adenovirus prolonged survival in mouse models of metastatic lung cancer and cleared tumors in about 35% of the animals.